一种检测肿瘤产生原始生殖细胞能力和效率的方法及用途

本发明属生物和医学检验技术领域,涉及检测肿瘤产生PGC样细胞能力和效率的方法,具体涉及一种检测肿瘤产生原始生殖细胞(Primordial germ cells,PGCs)样肿瘤细胞的能力的方法,本发明采用肿瘤组织或肿瘤组织培养物,检测其中原始生殖细胞(Primordial germ cells,PGCs)样肿瘤细胞的存在和/或形成效率,以及应用检测肿瘤组织及肿瘤组织培养物中与激活PGC样肿瘤细胞形成相关基因表达的变化,进一步用于预测肿瘤的转移能力和转移风险。 The invention belongs to the technical field of biological and medic...

Full description

Saved in:
Bibliographic Details
Format Patent
LanguageChinese
Published 22.08.2025
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:本发明属生物和医学检验技术领域,涉及检测肿瘤产生PGC样细胞能力和效率的方法,具体涉及一种检测肿瘤产生原始生殖细胞(Primordial germ cells,PGCs)样肿瘤细胞的能力的方法,本发明采用肿瘤组织或肿瘤组织培养物,检测其中原始生殖细胞(Primordial germ cells,PGCs)样肿瘤细胞的存在和/或形成效率,以及应用检测肿瘤组织及肿瘤组织培养物中与激活PGC样肿瘤细胞形成相关基因表达的变化,进一步用于预测肿瘤的转移能力和转移风险。 The invention belongs to the technical field of biological and medical examination, and relates to a method for detecting the capability and efficiency of tumors to generate PGC-like cells, in particular to a method for detecting the capability of the tumors to generate the PGCs-like tumor cells. According to the method, tumor tissues or tumor tissue cultures are adopted, the existence and/or formation efficiency of the PGC-like tumor cells are detected, and changes of gene expression related to activation of formation of the PGC-like tumor cells in the tumor tissues and tumor tissue cultures are detected, and the method is further used for predicting the metastasis capability and metastasis risk of the tumors.
Bibliography:Application Number: CN202010209518